Our lab has previously demonstrated that MIEN1 enhances the migration and invasion of prostate cancer cells by activating the Akt/NF-κB pathway which leads to an increase in certain proteases and angiogenic factors, and by altering actin cytoskeleton structures (propelling cellular movement) [24, 32]. Here, MIEN1 is linked to prostate cancer.